1.
Vazquez-Urrutia JR, Venugopal N, Zhu J, Komiya T. Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation–Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. World J Oncol. 2026;17(3):310-321. doi:10.14740/wjon2761